107 related articles for article (PubMed ID: 36152564)
41. Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
Casal-Mouriño A; Ruano-Ravina A; Torres-Durán M; Parente-Lamelas I; Provencio-Pulla M; Castro-Añón O; Vidal-García I; Pena-Álvarez C; Abal-Arca J; Piñeiro-Lamas M; Fuente-Merino I; Fernández-Villar A; Abdulkader I; Valdés-Cuadrado L; Barros-Dios JM; Pérez-Ríos M
Cancer Lett; 2020 Nov; 493():10. PubMed ID: 32810636
[No Abstract] [Full Text] [Related]
42. Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].
Bogusławska J; Rodzik K; Popławski P; Kędzierska H; Rybicka B; Sokół E; Tański Z; Piekiełko-Witkowska A
Cancer Lett; 2020 Jun; 480():52-55. PubMed ID: 32005526
[No Abstract] [Full Text] [Related]
43. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
[No Abstract] [Full Text] [Related]
44. Corrigendum to "Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8 + T cells in liver cancer" [Canc. Lett. 495 (2020) 1-11].
Qian J; Chen T; Wu Q; Zhou L; Zhou W; Wu L; Wang S; Lu J; Wang W; Li D; Xie H; Su R; Guo D; Liu Z; He N; Yin S; Zheng S
Cancer Lett; 2021 Feb; 498():242. PubMed ID: 33109412
[No Abstract] [Full Text] [Related]
45. Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
Cancer Lett; 2022 Jul; 539():215696. PubMed ID: 35477591
[No Abstract] [Full Text] [Related]
46. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
47. Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
Cancer Lett; 2020 Dec; 494():3-4. PubMed ID: 32827930
[No Abstract] [Full Text] [Related]
48. Retraction notice to "SRI36160 is a specific inhibitor of Wnt/-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
Li Y; Oliver PG; Lu W; Pathak V; Sridharan S; Augelli-Szafran CE; Buchsbaum DJ; Suto MJ
Cancer Lett; 2018 May; 422():131. PubMed ID: 29579438
[No Abstract] [Full Text] [Related]
49. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Moskovich D; Alfandari A; Finkelshtein Y; Weisz A; Katzav A; Kidron D; Edelstein E; Veroslavski D; Perets R; Arbib N; Kadan Y; Fishman A; Lerer B; Ellis M; Ashur-Fabian O
Cancer Lett; 2023 Jun; 563():216196. PubMed ID: 37104919
[No Abstract] [Full Text] [Related]
50. Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
Cancer Lett; 2022 Jan; 525():200-202. PubMed ID: 34785089
[No Abstract] [Full Text] [Related]
51. Corrigendum to "Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands" [Canc. Lett. 403 (2017) 98-107].
Allison SJ; Sadiq M; Baronou E; Cooper PA; Dunnill C; Georgopoulos NT; Latif A; Shepherd S; Shnyder SD; Stratford IJ; Wheelhouse RT; Willans CE; Phillips RM
Cancer Lett; 2018 Sep; 431():247. PubMed ID: 29934232
[No Abstract] [Full Text] [Related]
52. Corrigendum to "Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells" [Canc. Lett. 466 (2019) 1-12].
Wang J; Liu J; Sun G; Meng H; Wang J; Guan Y; Yin Y; Zhao Z; Dong X; Yin S; Li H; Cheng Y; Wu H; Wu A; Yu X; Chen L
Cancer Lett; 2021 Feb; 498():245-246. PubMed ID: 33342533
[No Abstract] [Full Text] [Related]
53. Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509].
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2021 Nov; 521():322-323. PubMed ID: 34521548
[No Abstract] [Full Text] [Related]
54. Corrigendum to "Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA."[Canc. Lett. (2005) 224 (1) 123-32].
Park SY; Cho SJ; Kwon HC; Lee KR; Rhee DK; Pyo S
Cancer Lett; 2019 Mar; 444():188. PubMed ID: 30528159
[No Abstract] [Full Text] [Related]
55. Corrigendum to "LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells" [Canc. Lett. 429 (2018) 89-99].
Fan H; Lv P; Mu T; Zhao X; Liu Y; Feng Y; Lv J; Liu M; Tang H
Cancer Lett; 2020 Dec; 494():84-87. PubMed ID: 32911100
[No Abstract] [Full Text] [Related]
56. Corrigendum to "
Zhou X; Zhang W; Dou M; Li Z; Liu Z; Li J; Tian C; Yao Y; Wang C; Li Y; Chen P; Han X; Jiao D
Cancer Lett; 2023 Jul; 567():216282. PubMed ID: 37344309
[No Abstract] [Full Text] [Related]
57. Corrigendum to "miR-346 functions as a pro-survival factor under ER stress by activating mitophagy" [Canc. Lett. 413 (2018) 69-81].
Guo J; Yang Z; Yang X; Li T; Liu M; Tang H
Cancer Lett; 2020 Nov; 493():11-12. PubMed ID: 32810637
[No Abstract] [Full Text] [Related]
58. Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].
Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
Cancer Lett; 2020 Mar; 472():181-182. PubMed ID: 31879079
[No Abstract] [Full Text] [Related]
59. Corrigendum to "Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma" [Canc. Lett. 503 (2021) 43-53].
Chen S; Yang M; Wang C; Ouyang Y; Chen X; Bai J; Hu Y; Song M; Zhang S; Zhang Q
Cancer Lett; 2022 Jul; 537():215688. PubMed ID: 35459579
[No Abstract] [Full Text] [Related]
60. Corrigendum to "Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy" [Canc. Lett 244 (2006) 182-189].
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2021 Feb; 498():244. PubMed ID: 33109413
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
